| Literature DB >> 28620156 |
Lixia Feng1, Huimin Lin2, Yao Chen2, Jiafeng Wang2, Yonghua Wang3,4, Rongfeng Liao2, Jiawei Zhou5,6, Robert F Hess7.
Abstract
Lasik is a common surgery for treating anisometropia. In this study, we asked a specific question: what's the effect of Lasik surgery on anisometropes' sensory eye dominance ? Fifteen myopic anisometropes (mean age: 23 ± 6.9 years old; 6 females) participated in our experiment. We quantitatively measured participants' sensory eye dominance before and after the Lasik surgery using a binocular phase combination paradigm. We found no significant change of sensory eye dominance within 16 weeks (measured between 8 to 96 days, for one or two repetitions) after the surgery (t(14) = -1.44, p = 0.17). A further following on eight patients showed that patients' two eyes were much more balanced at 16 weeks or more (measured one or two times between 112 to 408 days) after the surgery (t(7) = -3.79, p = 0.007). Our results suggest that the benefit of Lasik surgery on anisometropes' sensory eye dominance is not immediate, a long-term 'adaptation' period (16 weeks or more) is necessary to enable the surgery to be truly effective.Entities:
Mesh:
Year: 2017 PMID: 28620156 PMCID: PMC5472567 DOI: 10.1038/s41598-017-03553-8
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Illustration of the binocular phase combination paradigm. Two horizontal sine-wave gratings with equal and opposite phase-shifts of 22.5° (relative to the center of the screen) were dichoptically presented to the two eyes through the polarized glasses. The perceived phase of the cyclopean grating depends on the contribution of the two eyes in binocular phase combination. Sensory eye dominance is quantified by the interocular contrast difference that is needed to achieve a 0-degree of perceived phase, i.e., the balance point, where the two eyes are balanced in binocular phase combination.
Figure 2Patients’ sensory eye dominance before and after the surgery. Patients’ sensory eye dominance were quantified by individuals’ effective contrast ratio at balance point (i.e., the interocular contrast ratio that is needed when the two eyes are balanced in binocular phase combination) before and after surgery. The pre-surgery measurement is marked as open symbols; the post-surgery measurement that was measured within 16 weeks after the surgery is marked as black filled symbols and the post-surgery measurement that was measured at or longer than 16 weeks after the surgery is marked as red filled symbols. Except subjects S13, S14 and S15, who had a switch of eye dominance in one of the test sessions (marked as triangle symbols), most observers had consistent nondominant eye during this study.
Figure 3Sensory eye dominance before and within 16 weeks after the surgery. Each point represents the results of one subject. The average balance point and it’s standard error were marked using box and error bars for each time session.
Figure 4The long-term effect of surgery on patients’ sensory eye dominance. Each point represents the results of one subject. The average balance point and it’s standard error were marked using box and error bars for each time session. Eight patients participated in this study. **p < 0.01, 2-tailed paired-samples t-test.
Clinical details of the participants.
| Subject# | Age (years old) | Gender | Right eye | Left eye | ||||
|---|---|---|---|---|---|---|---|---|
| Refractive errors | Visual acuity (LogMAR) | Refractive errors | Visual acuity (LogMAR) | |||||
| Uncorrected | Corrected | Uncorrected | Corrected | |||||
| S1 | 18 | Male | −4.25 | 0.70 | 0.00 | −1.75 | 0.52 | 0.00 |
| S2 | 19 | Male | −4.50/−1.25@10 | 1.10 | 0.00 | −9.50/−3.25@155 | 1.70 | 0.00 |
| S3 | 20 | Male | −3.75 | 0.92 | 0.00 | −5.75 | 1.10 | 0.00 |
| S4 | 18 | Male | −5.75/−1.25@15 | 1.22 | 0.00 | −3.75/−2.50@170 | 1.00 | 0.10 |
| S5 | 18 | Female | −5.25/−0.25@15 | 0.92 | 0.00 | −3.00/−0.50@10 | 0.92 | 0.00 |
| S6 | 27 | Male | −3.25/−1.00@180 | 0.92 | 0.00 | −5.50/−0.50@10 | 1.30 | 0.00 |
| S7 | 19 | Female | −1.00 | 0.70 | 0.00 | −7.00/−0.50@100 | 1.70 | 0.00 |
| S8 | 20 | Male | −4.00/−3.25@10 | 1.70 | 0.00 | −7.00/−2.75@5 | 1.70 | 0.00 |
| S9 | 32 | Female | −6.00/−1.75@170 | 1.00 | 0.10 | −11.00/−1.50@5 | 1.22 | 0.10 |
| S10 | 43 | Female | Plano | 0.10 | 0.10 | −3.50/−1.00@160 | 1.00 | 0.10 |
| S11 | 25 | Male | −1.25/−3.00@180 | 0.60 | 0.10 | −3.50/−4.00@170 | 0.60 | 0.10 |
| S12 | 23 | Male | −2.75/−1.00@105 | 0.92 | 0.00 | Plano | 0.00 | 0.00 |
| S13 | 25 | Female | −9.00/−0.50@90 | 1.52 | 0.00 | Plano | 0.10 | 0.10 |
| S14 | 20 | Female | −6.75/−1.75@150 | 1.40 | 0.00 | −4.25/−1.25@10 | 1.30 | 0.00 |
| S15 | 18 | Male | −5.50 | 1.00 | 0.00 | −9.00/−1.75@170 | 1.00 | 0.00 |